Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › BIIB

SILVERARC CAPITAL MANAGEMENT, LLC position in BIIB

BIOGEN INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 112,790 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$25.5M, representing 3.25% of its reported portfolio and ranking #9 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed BIIB holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)112.79K sh
Reported value held$25.48M
Portfolio Weight3.25%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's BIIB position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in BIIB in Q3 2023 at 28,069 shares (US$7.2M). The position peaked in Q3 2026 at 112,790 shares, worth US$25.5M. Across 10 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 112,790 shares valued at US$25.5M — an increase of 64,689 shares quarter over quarter.. Notable position changes include a 29% trim in Q4 2023 (shares fell 17% over the following quarter), a 32% trim in Q1 2026 (shares rose 18% over the following quarter), a 134% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 28.07K $7.21M New
Q4 2023 20.00K $5.18M Reduce
Q1 2024 19.36K $4.18M Reduce
Q2 2024 19.36K $4.49M Hold
Q3 2024 19.94K $3.87M Add
Q3 2025 80.42K $11.27M New
Q4 2025 75.41K $13.27M Reduce
Q1 2026 50.97K $9.34M Reduce
Q2 2026 48.10K $10.39M Reduce
Q3 2026 112.79K $25.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held BIIB?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed BIIB holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in BIIB?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 112.79K shares of BIIB (BIOGEN INC), valued at $25.48M, representing 3.25% of its reported portfolio and ranking #9.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling BIIB?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in BIIB. The position peaked in Q3 2026 at 112.79K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.